Department for Work and Pensions

home

Site navigation


Clinical features

Area of body How affected

General symptoms

Sarcoidosis may cause general symptoms as listed opposite.

  • Uneasiness, feeling sick (malaise), an overall feeling of ill health 
  • Tiredness, fatigue, weakness
  • Loss of appetite or weight
  • Fever
  • Night sweats
  • Sleep problems

Lungs

Most affected organ, affects more than 90% of patients

(In about 50% of cases, the diagnosis is made on a routine Chest X- ray in a person who has no symptoms)

  • Enlarged lymph nodes at the hila of the lung or around the trachea
  • Infiltration of the lung tissue with normal lung function in early stages; breathlessness on effort, (small stiff lungs), and a restrictive lung disease picture in advanced disease)
  • There are 4 “stages” of lung involvement - (see below)*

Skin

The second most commonly affected organ

Manifestations can be:

  • In Europeans, erythema nodosum (raised, tender red lumps on the shins)
  • Flat patches (plaques) in the skin in longstanding disease with raised waxy patches in skin and discoloration of the nose lips, ears and cheeks (Lupus Pernio); this occurs more in black females.
  • Hyperpigmentation (excess pigment)
  • Hypopigmentation (reduced pigment)
  • Keloid reaction (thickened scarring of the skin following injury)

Eye manifestations

(Occur in around 15% to 25% of cases)

  • Anterior and posterior uveitis (inflammation of the internal eye)
  • Glaucoma due to the blockage to the drainage of intra- ocular fluid
  • Dry eyes (Keratoconjunctivis Sicca) partly caused by sluggish lachrymal gland secretion
  • Conjunctivitis
  • Conjunctival granulomas
  • Retinal lesions
  • Optic nerve involvement

Anterior uveitis usually is short- lived, posterior uveitis is generally a more chronic condition. Blindness is rare.

Central Nervous System manifestations

Involvement is rare (2%), but the effects can be serious

  • Cranial nerves may be affected
  • Facial palsy (paralysis of the facial nerve) often bilateral is a well recognised complaint. This is known as Bell’s Palsy.
  • Spinal cord disease
  • Polyneuropathy
  • Chronic meningoencephalitis
  • Diabetes Insipidus (a condition of impaired water balance in the body)

Bone and Joint Involvement

(5%)

  • Fever and joint pain (arthralgia) in Europeans, occurring more commonly in acute disease
  • Bone cysts in the fingers (granulomas affect the bone and may lead to hypercalcaemia - high blood calcium)
  • Hands and feet most commonly affected.

Liver and Spleen

(70% liver involvement, 50% liver and spleen involvement)

  • Spleen can enlarge, occasionally the enlargement is massive, necessitating removal of the spleen.
  • 70% have liver granulomas
  • However disease causes symptoms in less than 10%

Heart Involvement

(3%)

Less common, more serious, and more difficult to identify

Metabolic

Hypercalcaemia is found in 10% of established cases. It can lead to the formation of renal stones and other kidney problems.

* The four lung stages used in the classification of Sarcoidosis (based on chest radiological appearances) are:

1. Hilar lymphadenopathy (enlarged lymph glands at the hila of the lungs) [a person who demonstrates this has a 90% rate of resolution of the disease within 2 to 5 years]

2. Adenopathy (lymph glands affected) & parenchymal (lung tissue) disease co-exist in 30% of cases. [In about 50% of these cases, spontaneous resolutionoccurs within 2 years].

3. Parenchymal disease alone [a person who demonstrates this has a 30% chance of resolution of the disease].

4. Lung fibrosis. This can lead to progressive respiratory failure.

NB. This classification does not relate to the chronological progression of the disease but has international recognition.

From Oxford Textbook of Medicine, 4th edition, Volume2

A restrictive pattern (FEV1/ FVC ratio = normal or increased on lung function studies is normally demonstrated, with reduced lung volumes, but occasionally, an obstructive picture (FEV1/ FVC ratio = less than 75%) can occur. This can occur in smokers or those with endobronchial sarcoid.

For Lung Function Tests in Asthma and COPD:

Amended December 2011